This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Marco Minuth, PhD
Director Oligo R&D II at Bachem
Speaker

Profile

Marco Minuth is Director Oligo R&D II at Bachem, where he leads a team dedicated to advancing process development for therapeutic oligonucleotides and pioneering new manufacturing technologies. He earned his PhD in organic chemistry from the University of Stuttgart, focusing on the synthesis of C‑nucleosides for high‑fidelity base pairing in oligonucleotides. Marco joined Bachem in 2015 as a project chemist in the API division and subsequently held several positions within Peptide R&D before transitioning back to oligonucleotide development as Senior Group Leader CMC, ultimately progressing into his current role.

Agenda Sessions

  • Stirring Things Up: Integrating Stirred-Bed SPOS and Enzymatic Ligation for Industrial Oligonucleotide Production

    12:20pm